Literature DB >> 24398869

Dent's disease complicated by an acute Budd-Chiari syndrome.

Caroline Platt1, Lyda Jadresic, Jan Dudley, Jane L Hartley.   

Abstract

We present the case of a young boy with Dent's disease, identified as having a mutation in the kidney-specific chloride-proton antitransporter CLCN5 during investigation for nephrotic-range proteinuria. He went on to develop growth hormone deficiency and was treated with recombinant growth hormone. He later presented acutely with hepatorenal failure and thrombotic occlusion of the middle and right hepatic veins consistent with a diagnosis of Budd-Chiari syndrome, which required a prolonged period of intensive care. The diagnosis of Dent's disease should be considered early in boys with nephrotic-range proteinuria in the absence of clinical oedema and hypoalbuminaemia to allow for the timely introduction of strategies, such as a high-citrate diet, to preserve renal function. The measurement of urinary β-2 microglobulin has been shown by this case to be a more reliable and specific marker of tubular dysfunction than the urinary retinol-binding protein.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24398869      PMCID: PMC3902325          DOI: 10.1136/bcr-2013-200937

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  9 in total

Review 1.  The Budd-Chiari syndrome.

Authors:  K V Narayanan Menon; Vijay Shah; Patrick S Kamath
Journal:  N Engl J Med       Date:  2004-02-05       Impact factor: 91.245

Review 2.  X-linked hypercalciuric nephrolithiasis: clinical syndromes and chloride channel mutations.

Authors:  S J Scheinman
Journal:  Kidney Int       Date:  1998-01       Impact factor: 10.612

Review 3.  New insights into the roles of megalin/LRP2 and the regulation of its functional expression.

Authors:  María-Paz Marzolo; Pamela Farfán
Journal:  Biol Res       Date:  2011-05-11       Impact factor: 5.612

4.  High citrate diet delays progression of renal insufficiency in the ClC-5 knockout mouse model of Dent's disease.

Authors:  Valeriu Cebotaru; Sadhana Kaul; Olivier Devuyst; Hui Cai; Lorraine Racusen; William B Guggino; Sandra E Guggino
Journal:  Kidney Int       Date:  2005-08       Impact factor: 10.612

Review 5.  Chloride channels and endocytosis: new insights from Dent's disease and ClC-5 knockout mice.

Authors:  Olivier Devuyst; François Jouret; Céline Auzanneau; Pierre J Courtoy
Journal:  Nephron Physiol       Date:  2005

6.  Dent's disease: clinical features and molecular basis.

Authors:  Félix Claverie-Martín; Elena Ramos-Trujillo; Víctor García-Nieto
Journal:  Pediatr Nephrol       Date:  2010-10-10       Impact factor: 3.714

Review 7.  The influence of pituitary, adrenal, and parathyroid hormones on hemostasis and thrombosis.

Authors:  Alessandro Squizzato; Bregje Van Zaane; Victor E A Gerdes; Harry R Büller
Journal:  Semin Thromb Hemost       Date:  2011-01-19       Impact factor: 4.180

8.  Growth hormone improves growth rate and preserves renal function in Dent disease.

Authors:  Sharone Sheffer-Babila; Manju Chandra; Phyllis W Speiser
Journal:  J Pediatr Endocrinol Metab       Date:  2008-03       Impact factor: 1.634

9.  Effect of growth hormone replacement therapy in a boy with Dent's disease: a case report.

Authors:  Mira Samardzic; Snezana Pavicevic; Michael Ludwig; Radovan Bogdanovic
Journal:  J Med Case Rep       Date:  2011-08-22
  9 in total
  1 in total

Review 1.  Genetics and phenotypic heterogeneity of Dent disease: the dark side of the moon.

Authors:  Lisa Gianesello; Dorella Del Prete; Franca Anglani; Lorenzo A Calò
Journal:  Hum Genet       Date:  2020-08-29       Impact factor: 4.132

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.